- Home
- DIBS vs LENZ Comparison
DIBS vs LENZ Comparison
Compare DIBS & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DIBS | LENZ |
|---|---|---|
| Founded | 2000 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.9M | 142.0M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DIBS | LENZ |
|---|---|---|
| Price | $4.32 | $4.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $7.00 | ★ $44.00 |
| AVG Volume (30 Days) | 69.3K | ★ 593.2K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.45 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $89,620,000.00 | $19,088,000.00 |
| Revenue This Year | $3.12 | $50.42 |
| Revenue Next Year | $1.72 | $197.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.54 | N/A |
| 52 Week Low | $2.50 | $4.50 |
| 52 Week High | $6.62 | $50.19 |
Technical Indicators
Market Signals| Indicator | DIBS | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 41.83 | 39.29 |
| Support Level | $4.03 | N/A |
| Resistance Level | $4.90 | $6.11 |
| Average True Range (ATR) | 0.23 | 0.33 |
| MACD | -0.04 | -0.05 |
| Stochastic Oscillator | 13.04 | 3.38 |
Price Performance
Historical ComparisonAbout DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company has a single reportable and operating segment that contains one reporting unit, which consists of the company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.